Pardeep Ratnani, DO
Nephrology · Fort Worth, TXNPI 1265992325
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,728 of the $2,119 with a category attached, or 81.6%. 21 manufacturers reported payments, led by Medtronic at 37.4% of the total. Reporting peaked in 2023 at $1,352 and has fallen 54.1% since, to $621 in 2025.
Across 51 payments — averaging $41.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$792
- Amgen$247
- Mallinckrodt Hospital Products Inc.$189
- Otsuka America Pharmaceutical, Inc.$167
- GSK$118
- Aurinia Pharma U.S., Inc.$100
- plus $505 from 15 others
What the payments were for
- Travel & lodging$37017%
- Food & beverage$1,72882%
- Education$201%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 8 | $792 |
| Amgen(2 entities) | 10 | $247 |
| Mallinckrodt Hospital Products Inc. | 4 | $189 |
| Otsuka America Pharmaceutical, Inc. | 3 | $167 |
| GSK | 1 | $118 |
| Aurinia Pharma U.S., Inc. | 4 | $100 |
| Veloxis Pharmaceuticals, Inc. | 2 | $83 |
| Bayer | 3 | $63 |
| Fresenius USA Marketing, Inc. | 2 | $49 |
| Scpharmaceuticals Inc. | 2 | $38 |
| Calliditas Therapeutics US Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Novartis | 1 | $31 |
| Sanofi | 1 | $28 |
| Genentech USA, Inc. | 1 | $28 |
| AstraZeneca | 1 | $27 |
| Ardelyx, Inc. | 1 | $27 |
| Mannkind Corporation | 1 | $22 |
| Akebia Therapeutics Inc | 1 | $16 |
| Baxter Healthcare | 1 | $15 |
| Novo Nordisk | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELLIPSYS VASCULAR ACCESS SYSTEM$516
- JYNARQUE$125
- TERLIVAZ$120
How this compares
$2,119 in reported general payments places this provider in the 55th percentile of 1,070 nephrology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Fort Worth
- Saravanan BalamuthusamyFort Worth$435K
- Sandeep ShoriFort Worth$195K
- Michael AragonFort Worth$138K
- Abdul AbdellatifWebster$2.1M
- German HernandezEl Paso$1.3M
- Ankit MehtaDallas$1.1M
- Biff PalmerDallas$867K
- Gates ColbertDallas$828K
- Sreedhar MandayamHouston$752K
- Luis VelezSan Antonio$505K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.